Concerning clinical stages T and N, our results failed to find an association between podoplanin expression and the clinical stages of the tumor, probably because we included only T2 and T3 tumors, while in other studies, the tumor stages varied from I to IV [14, 16, 19, 20, 30]. This evidence concerns the gene PDPN and neoplasm.